HTD News and Press, John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest From 03/29/23

2023-03-29 13:22:07 ET Summary Investors are desperately in need of income simply to maintain their lifestyles in today's inflationary environment. Eaton Vance Tax-Managed Buy-Write Opportunities Fund uses an interesting strategy of owning a portfolio of stocks and writing call op...

MENLO PARK, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the h...

2023-03-28 12:39:49 ET Summary Investors today, like all Americans, are desperately in need of extra income to maintain their lifestyles in the face of high rates of inflation. John Hancock Tax-Advantaged Dividend Income Fund invests in a portfolio of dividend stocks and then appl...

2023-03-09 15:14:17 ET Summary Data aggregator websites such as Morningstar or CEFData are merely places to get initial ideas. With CEFs that can get rather niche and are actively managed, it becomes even more imperative as things change constantly. CEF misclassifications can ...

2023-03-09 05:23:39 ET Summary First Trust CEF Income Opportunity ETF is an actively managed fund of funds. It has outperformed its competitors YYY and PCEF since 2016. Distribution growth has outpaced inflation, but share price has lagged it. The main issues of this fund ...

MENLO PARK, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (Nasdaq: CORT) (“ Corcept ”), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by...

Summary As in Led Zeppelin’s famous song, for me, investments in high-dividend securities represent a kind of stairway to heaven. Indeed, their steady flow of money relieves psychological pressure during times of market uncertainty and helps me experience them with greater peace ...

MENLO PARK, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the ho...

JOHN HANCOCK FINANCIAL OPPORTUNITIES FUND; JOHN HANCOCK HEDGED EQUITY & INCOME FUND; JOHN HANCOCK PREFERRED INCOME FUND; JOHN HANCOCK PREFERRED INCOME FUND II; JOHN HANCOCK PREFERRED INCOME FUND III; JOHN HANCOCK PREMIUM DIVIDEND FUND; JOHN HANCOCK TAX-ADVANTAGED DIVIDEND INCOME FUND; JOHN HA...

Summary The market started out with a bang in 2023 after a lackluster 2022. My CEF portfolio had some significant losses thanks to poor positioning in tech-related funds and discount widening across the board. BSTZ being my top holding heading into 2022, is one standout detractor th...